![Peter Weiler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Peter Weiler worked as Senior Director-Analysis & Research at DRI Capital, Inc. He then worked as Vice President-Business Development at BioSyent, Inc. from 2017 to 2018 and at Cipher Pharmaceuticals, Inc. from 2008 to 2017.
Mr. Weiler holds a graduate degree from the University of Western Ontario and an MBA from Richard Ivey School of Business.
Precedenti posizioni note di Peter Weiler
Società | Posizione | Fine |
---|---|---|
BIOSYENT INC. | Corporate Officer/Principal | 01/09/2018 |
CIPHER PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/05/2017 |
DRI Capital, Inc.
![]() DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
Formazione di Peter Weiler
University of Western Ontario | Graduate Degree |
Richard Ivey School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
CIPHER PHARMACEUTICALS INC. | Health Technology |
BIOSYENT INC. | Health Technology |
Aziende private | 1 |
---|---|
DRI Capital, Inc.
![]() DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Finance |
- Borsa valori
- Insiders
- Peter Weiler